Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 201

Similar articles for PubMed (Select 24332490)

1.

Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.

Kolundžija B, Marković V, Stanojković T, Joksović L, Matić I, Todorović N, Nikolić M, Joksović MD.

Bioorg Med Chem Lett. 2014 Jan 1;24(1):65-71. doi: 10.1016/j.bmcl.2013.11.075. Epub 2013 Dec 4.

PMID:
24332490
2.

Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.

Wang G, Li C, He L, Lei K, Wang F, Pu Y, Yang Z, Cao D, Ma L, Chen J, Sang Y, Liang X, Xiang M, Peng A, Wei Y, Chen L.

Bioorg Med Chem. 2014 Apr 1;22(7):2060-79. doi: 10.1016/j.bmc.2014.02.028. Epub 2014 Mar 1.

PMID:
24629450
3.

Anti-tumor activity of new artemisinin-chalcone hybrids.

Xie L, Zhai X, Liu C, Li P, Li Y, Guo G, Gong P.

Arch Pharm (Weinheim). 2011 Oct;344(10):639-47. doi: 10.1002/ardp.201000391. Epub 2011 Aug 25.

PMID:
21984014
4.

Design, synthesis, and antiangiogenic effects of a series of potent novel fumagillin analogues.

Lee HW, Cho CS, Kang SK, Yoo YS, Shin JS, Ahn SK.

Chem Pharm Bull (Tokyo). 2007 Jul;55(7):1024-9.

5.

Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.

Wang G, Wang F, Cao D, Liu Y, Zhang R, Ye H, Li X, He L, Yang Z, Ma L, Peng A, Xiang M, Wei Y, Chen L.

Bioorg Med Chem Lett. 2014 Jul 15;24(14):3158-63. doi: 10.1016/j.bmcl.2014.04.121. Epub 2014 May 16.

PMID:
24863745
6.

Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.

Rane RA, Sahu NU, Gutte SD, Mahajan AA, Shah CP, Bangalore P.

Eur J Med Chem. 2013 May;63:793-9. doi: 10.1016/j.ejmech.2013.03.029. Epub 2013 Mar 26.

PMID:
23584542
7.

Anthraquinone-chalcone hybrids: synthesis, preliminary antiproliferative evaluation and DNA-interaction studies.

Marković V, Debeljak N, Stanojković T, Kolundžija B, Sladić D, Vujčić M, Janović B, Tanić N, Perović M, Tešić V, Antić J, Joksović MD.

Eur J Med Chem. 2015 Jan 7;89:401-10. doi: 10.1016/j.ejmech.2014.10.055. Epub 2014 Oct 18.

PMID:
25462255
8.

Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.

Taher AT, Hegazy GH.

Arch Pharm Res. 2013 May;36(5):573-8. doi: 10.1007/s12272-013-0074-x. Epub 2013 Mar 8.

PMID:
23471561
9.

Anti-breast cancer activity of heteroaryl chalcone derivatives.

Solomon VR, Lee H.

Biomed Pharmacother. 2012 Apr;66(3):213-20. doi: 10.1016/j.biopha.2011.11.013. Epub 2011 Dec 31.

PMID:
22440895
10.

Synthesis and biological evaluation of bifendate-chalcone hybrids as a new class of potential P-glycoprotein inhibitors.

Gu X, Ren Z, Tang X, Peng H, Ma Y, Lai Y, Peng S, Zhang Y.

Bioorg Med Chem. 2012 Apr 15;20(8):2540-8. doi: 10.1016/j.bmc.2012.02.050. Epub 2012 Mar 3.

PMID:
22429509
11.

Synthesis and antitumor activity of novel chalcone derivatives.

Jin C, Liang YJ, He H, Fu L.

Biomed Pharmacother. 2013 Apr;67(3):215-7. doi: 10.1016/j.biopha.2010.12.010. Epub 2010 Dec 30.

PMID:
23478573
12.

Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.

Conconi MT, Marzaro G, Urbani L, Zanusso I, Di Liddo R, Castagliuolo I, Brun P, Tonus F, Ferrarese A, Guiotto A, Chilin A.

Eur J Med Chem. 2013 Sep;67:373-83. doi: 10.1016/j.ejmech.2013.06.057. Epub 2013 Jul 6.

PMID:
23900004
13.

Synthesis, cytotoxic activity and DNA-interaction studies of novel anthraquinone-thiosemicarbazones with tautomerizable methylene group.

Marković V, Janićijević A, Stanojković T, Kolundžija B, Sladić D, Vujčić M, Janović B, Joksović L, Djurdjević PT, Todorović N, Trifunović S, Joksović MD.

Eur J Med Chem. 2013 Jun;64:228-38. doi: 10.1016/j.ejmech.2013.03.071. Epub 2013 Apr 9.

PMID:
23644206
14.

Phenylpropiophenone derivatives as potential anticancer agents: synthesis, biological evaluation and quantitative structure-activity relationship study.

Ivković BM, Nikolic K, Ilić BB, Žižak ŽS, Novaković RB, Čudina OA, Vladimirov SM.

Eur J Med Chem. 2013 May;63:239-55. doi: 10.1016/j.ejmech.2013.02.013. Epub 2013 Feb 20.

PMID:
23501110
15.

Design, synthesis and antitumor activity of novel artemisinin derivatives using hybrid approach.

Xie L, Zhai X, Ren L, Meng H, Liu C, Zhu W, Zhao Y.

Chem Pharm Bull (Tokyo). 2011;59(8):984-90.

16.

Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.

Jin GZ, Jin HS, Jin LL.

Arch Pharm Res. 2011 Jul;34(7):1071-6. doi: 10.1007/s12272-011-0704-0. Epub 2011 Aug 3.

PMID:
21811913
17.

Synthesis and cytotoxic evaluation of novel symmetrical taspine derivatives as anticancer agents.

Zhang J, Zhang Y, Pan X, Wang S, He L.

Med Chem. 2011 Jul;7(4):286-94.

PMID:
21568882
18.

(E)-4-aryl-4-oxo-2-butenoic acid amides, chalcone-aroylacrylic acid chimeras: design, antiproliferative activity and inhibition of tubulin polymerization.

Vitorović-Todorović MD, Erić-Nikolić A, Kolundžija B, Hamel E, Ristić S, Juranić IO, Drakulić BJ.

Eur J Med Chem. 2013 Apr;62:40-50. doi: 10.1016/j.ejmech.2013.01.006. Epub 2013 Jan 11.

19.

Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents.

Liang YK, Yue ZZ, Li JX, Tan C, Miao ZH, Tan WF, Yang CH.

Eur J Med Chem. 2014 Sep 12;84:505-15. doi: 10.1016/j.ejmech.2014.07.047. Epub 2014 Jul 15.

PMID:
25050882
20.

Synthesis and cytotoxicity of 2,5-dihydroxychalcones and related compounds.

Nam NH, Hong DH, You YJ, Kim Y, Bang SC, Kim HM, Ahn BZ.

Arch Pharm Res. 2004 Jun;27(6):581-8.

PMID:
15283456
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk